Irnocel 40 mg Injection
20,42$
15,16$
Irnocel 40 mg Injection serves as a potent topoisomerase inhibitor specifically designed for patients battling advanced colorectal cancer. This innovative treatment may be administered alongside 5-fluorouracil and folinic acid, particularly for those who have not undergone prior chemotherapy for their advanced disease. By targeting the DNA replication process, Irnocel effectively disrupts cancer cell proliferation, providing a crucial option in a challenging treatment landscape. Patients considering this therapy should be aware of potential side effects, including gastrointestinal disturbances and blood count alterations, making regular monitoring essential. It is important to discuss any existing health conditions or medications with a healthcare provider to avoid adverse interactions. As part of a comprehensive cancer treatment plan, Irnocel offers hope for improved outcomes in advanced colorectal cancer. Always consult with a healthcare professional for personalized advice and information regarding this injection.
Quantité
Active Pharmaceutical Ingredient
Uses
• Irnocel 40 mg injection is primarily used in the treatment of certain types of cancer. Administered by healthcare professionals, this medication is delivered intravenously to ensure effective absorption. Its use is often part of a broader chemotherapy regimen tailored to the patient's specific cancer type. By targeting cancer cells, Irnocel 40 mg injection helps inhibit tumor growth and progression.
• In clinical settings, Irnocel 40 mg injection is utilized as a key component in combination therapy for enhancing treatment efficacy. This approach allows for a synergistic effect when used alongside other chemotherapeutic agents. Oncologists carefully design treatment plans that include Irnocel 40 mg injection to maximize patient outcomes. This medicine is particularly valuable in cases where multi-drug strategies are necessary to combat aggressive tumors.
• The administration of Irnocel 40 mg injection is typically guided by the patient's individual needs and the specifics of their cancer diagnosis. Healthcare providers assess various factors, including the type and stage of cancer, to determine the appropriate use of this medication. By customizing treatment regimens, Irnocel 40 mg injection can be more effectively integrated into a patient’s overall care plan. This personalized approach aims to enhance the therapeutic benefits while managing the disease.
• Irnocel 40 mg injection plays a crucial role in the management of cancer by providing targeted treatment options for patients. Its intravenous delivery method allows for rapid action within the body, making it suitable for acute treatment scenarios. In a hospital or clinical environment, healthcare teams closely monitor the patient's response to Irnocel 40 mg injection as part of their ongoing cancer care. This careful oversight helps optimize treatment effectiveness and improve patient quality of life during therapy.
Benefits
Treatment of colon and rectum cancer: Cancer of the colon and rectum, also known as colorectal cancer (CRC) or bowel cancer, is the development of cancer from two parts of the large intestine, namely, the colon or rectum. In this type of cancer, the person may notice symptoms such as blood in the stool, a change in bowel movements, weight loss, and fatigue. Irnocel 40 mg Injection treats and also lowers the risk of developing further cancerous growths (polyps) and bowel cancer. It kills or stops the growth of cancer cells and also prevents the multiplication of cancer cells. It is an effective, yet very toxic medicine and you should discuss the risks and benefits with your doctor. Avoid drinking alcohol or smoking while having this treatment and drink plenty of water to stay hydrated.
Side Effects
Like all medications, Uses of Irnocel 40 mg Injection can cause side effects but do not require any medical attention and disappear as your body adjusts to the medicine. Consult your doctor if they persist or if you’re worried about them.
Most Common Side Effects
• Nausea
• Vomiting
• Constipation
• Fever
• Infection
• Pain
Common Side Effects
• Diarrhea
• Kidney Impairment
• Lung Problems
• Low blood count
How To Use
Benefits of Irnocel 40 mg Injection is administered by a qualified doctor or nurse at a hospital or clinical setting. It is given intravenously and is usually given as part of a combination chemotherapy regimen. The specific treatment plan and dosage will depend on the type and stage of the cancer being treated, as well as other individual factors determined by the healthcare provider.
Safety Advice
• Alcohol: It is generally not recommended to drink alcohol while taking Irnocel 40 mg Injection. It may increase the risk of liver damage. it is best to avoid alcohol or limit your alcohol consumption while taking any medication.
• Kidney: Irnocel 40 mg Injection should be used with caution in patients with kidney disease. It is important that patients with kidney disease closely monitor kidney function while taking Irnocel 40 mg and report any unusual symptoms or changes in kidney function to their doctor. Irnocel 40 mg Injection is not recommended for use in patients on dialysis.
• Breastfeeding: The available data are limited but suggest that Irnocel 40 mg Injection and its metabolite are excreted in human milk. Consequently, because of the potential for adverse reactions in nursing infants, breastfeeding should be discontinued for the duration of How Irnocel 40 mg Injection works therapy.
• Liver: Benefits of Irnocel 40 mg Injection should be used with caution in patients with liver disease. It is important that patients with liver disease closely monitor liver function while taking Uses of Irnocel 40 mg Injection and report any unusual symptoms or changes in liver function to their doctor. The dose of Irnocel 40 mg Injection may need to be adjusted in patients with liver disease.
• Pregnancy: There are limited data on the use of irinotecan in pregnant women. Benefits of Irnocel 40 mg Injection has been shown to be embryotoxic and teratogenic in animals. Therefore, based on results from animal studies and the mechanism of action of Irnocel 40 mg, Irnocel 40 mg Injection should not be used during pregnancy unless clearly necessary. Women of childbearing potential should not be started on Side effects of Irnocel 40 mg Injection until pregnancy is excluded. Pregnancy should be avoided if either partner is receiving Irnocel 40 mg Injection.
• Driving: Irnocel 40 mg Injection has a moderate influence on the ability to drive and use machines. Patients should be warned about the potential for dizziness or visual disturbances, which may occur within 24 hours following the administration of Side effects of Irnocel 40 mg Injection, and advised not to drive or operate machinery if these symptoms occur.